<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35173169</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection.</ArticleTitle><Pagination><StartPage>890</StartPage><MedlinePgn>890</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">890</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-28533-z</ELocationID><Abstract><AbstractText>Hand, foot and mouth disease (HFMD) caused by Human Enterovirus A71 (HEVA71) infection is typically a benign infection. However, in minority of cases, children can develop severe neuropathology that culminate in fatality. Approximately 36.9% of HEVA71-related hospitalizations develop neurological complications, of which 10.5% are fatal. Yet, the mechanism by which HEVA71 induces these neurological deficits remain unclear. Here, we show that HEVA71-infected astrocytes release CXCL1 which supports viral replication in neurons by activating the CXCR2 receptor-associated ERK1/2 signaling pathway. Elevated CXCL1 levels correlates with disease severity in a HEVA71-infected mice model. In humans infected with HEVA71, high CXCL1 levels are only present in patients presenting neurological complications. CXCL1 release is specifically triggered by VP4 synthesis in HEVA71-infected astrocytes, which then acts via its receptor CXCR2 to enhance viral replication in neurons. Perturbing CXCL1 signaling or VP4 myristylation strongly attenuates viral replication. Treatment with AZD5069, a CXCL1-specific competitor, improves survival and lessens disease severity in infected animals. Collectively, these results highlight the CXCL1-CXCR2 signaling pathway as a potential target against HFMD neuropathogenesis.</AbstractText><CopyrightInformation>© 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gunaseelan</LastName><ForeName>Saravanan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National University of Singapore, Singapore, 117597, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LSI Neurobiology Programme, National University of Singapore, Singapore, 117456, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariffin</LastName><ForeName>Mohammed Zacky</ForeName><Initials>MZ</Initials><Identifier Source="ORCID">0000-0002-6228-3830</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanna</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7304-6259</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LSI Neurobiology Programme, National University of Singapore, Singapore, 117456, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Mong How</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Sarawak General Hospital, Kuching, Sarawak, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health and Community Medicine, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Health and Community Medicine, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Justin Jang Hann</ForeName><Initials>JJH</Initials><Identifier Source="ORCID">0000-0002-1673-6819</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National University of Singapore, Singapore, 117597, Singapore. miccjh@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. miccjh@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Translational Research Programme, National University of Singapore, Singapore, 117597, Singapore. miccjh@nus.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>John Jia En</ForeName><Initials>JJE</Initials><Identifier Source="ORCID">0000-0002-5615-1014</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. phsjcje@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LSI Neurobiology Programme, National University of Singapore, Singapore, 117456, Singapore. phsjcje@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. phsjcje@nus.edu.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. phsjcje@nus.edu.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016441">Retracted Publication</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C475829">CXCL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000629781">CXCR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054360">Chemokine CXCL1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000597960">N-(2-(2,3-difluoro-6-benzylthio)-6-(3,4-dihydroxybutan-2-yloxy)pyrimidin-4-yl)azetidine-1-sulfonamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023063">Receptors, Interleukin-8B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Commun. 2022 Mar 24;13(1):1693. doi: 10.1038/s41467-022-29362-w</RefSource><PMID Version="1">35332160</PMID></CommentsCorrections><CommentsCorrections RefType="RetractionIn"><RefSource>Nat Commun. 2023 Feb 24;14(1):1053. doi: 10.1038/s41467-023-36751-2</RefSource><PMID Version="1">36828847</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002493" MajorTopicYN="N">Central Nervous System Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054360" MajorTopicYN="N">Chemokine CXCL1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023063" MajorTopicYN="N">Receptors, Interleukin-8B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35173169</ArticleId><ArticleId IdType="pmc">PMC8850555</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-28533-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-28533-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304–309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh WM, Badaruddin H, La H, Chen MI, Cook AR. Severity and burden of hand, foot and mouth disease in Asia: a modelling study. BMJ Glob. Health. 2018;3:e000442. doi: 10.1136/bmjgh-2017-000442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2017-000442</ArticleId><ArticleId IdType="pmc">PMC5859810</ArticleId><ArticleId IdType="pubmed">29564154</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh WM, et al. The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis. Pediatr. Infect. Dis. J. 2016;35:e285–e300. doi: 10.1097/INF.0000000000001242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001242</ArticleId><ArticleId IdType="pmc">PMC5130063</ArticleId><ArticleId IdType="pubmed">27273688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaseelan, S. &amp; Chu, J. J. H. Identifying novel antiviral targets against enterovirus 71: where are we? Future Virol.10.2217/fvl-2016-0144 (2017).</Citation></Reference><Reference><Citation>Chang LY, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 2007;356:1226–1234. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Thong WY, et al. Enterovirus infections in Singaporean children: an assessment of neurological manifestations and clinical outcomes. Singap. Med. J. 2017;58:189–195. doi: 10.11622/smedj.2016099.</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2016099</ArticleId><ArticleId IdType="pmc">PMC5392603</ArticleId><ArticleId IdType="pubmed">27245861</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang YC, Lin TY. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet. 1998;352:367–368. doi: 10.1016/S0140-6736(98)24031-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)24031-1</ArticleId><ArticleId IdType="pubmed">9717926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res. 2000;68:127–136. doi: 10.1016/S0168-1702(00)00162-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(00)00162-3</ArticleId><ArticleId IdType="pubmed">10958984</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778–790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Lei H-Y, Liu C-C. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin. Dev. Immunol. 2012;2012:876241–876241. doi: 10.1155/2012/876241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/876241</ArticleId><ArticleId IdType="pmc">PMC3432373</ArticleId><ArticleId IdType="pubmed">22956971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767–3776. doi: 10.1128/JVI.06687-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, et al. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 2014;88:9830–9841. doi: 10.1128/JVI.01425-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01425-14</ArticleId><ArticleId IdType="pmc">PMC4136319</ArticleId><ArticleId IdType="pubmed">24942571</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo FMS, et al. Cytokine and chemokine profiling in patients with hand, foot and mouth disease in Singapore and Malaysia. Sci. Rep. 2018;8:4087–4087. doi: 10.1038/s41598-018-22379-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22379-6</ArticleId><ArticleId IdType="pmc">PMC5840398</ArticleId><ArticleId IdType="pubmed">29511232</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang R, Wu W, Duan G. Antiviral and inflammatory cellular signaling associated with Enterovirus 71 infection. Viruses. 2018;10:155. doi: 10.3390/v10040155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10040155</ArticleId><ArticleId IdType="pmc">PMC5923449</ArticleId><ArticleId IdType="pubmed">29597291</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 2012;86:2121–2131. doi: 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect. 2011;13:862–870. doi: 10.1016/j.micinf.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.04.004</ArticleId><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch. Virol. 2012;157:539–543. doi: 10.1007/s00705-011-1198-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1198-2</ArticleId><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis. Sci. Rep. 2018;8:1658–1658. doi: 10.1038/s41598-018-19988-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19988-6</ArticleId><ArticleId IdType="pmc">PMC5786096</ArticleId><ArticleId IdType="pubmed">29374213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye N, et al. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect. Dis. 2015;15:225. doi: 10.1186/s12879-015-0965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0965-1</ArticleId><ArticleId IdType="pmc">PMC4461975</ArticleId><ArticleId IdType="pubmed">26058678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease. PLoS ONE. 2013;8:e67430. doi: 10.1371/journal.pone.0067430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067430</ArticleId><ArticleId IdType="pmc">PMC3696071</ArticleId><ArticleId IdType="pubmed">23840697</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, et al. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 2003;163:1379–1393. doi: 10.1016/S0002-9440(10)63496-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63496-7</ArticleId><ArticleId IdType="pmc">PMC1868316</ArticleId><ArticleId IdType="pubmed">14507646</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, et al. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 1999;341:936–942. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929–935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, et al. Characterization of coxsackievirus A6- and enterovirus 71-associated hand foot and mouth disease in Beijing, China, from 2013 to 2015. Front. Microbiol. 2016;7:391–391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4812011</ArticleId><ArticleId IdType="pubmed">27065963</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol. J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Too IH, et al. Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway. Sci. Rep. 2016;6:36983. doi: 10.1038/srep36983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36983</ArticleId><ArticleId IdType="pmc">PMC5111112</ArticleId><ArticleId IdType="pubmed">27849036</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, et al. Producing infectious enterovirus type 71 in a rapid strategy. Virol. J. 2010;7:116. doi: 10.1186/1743-422X-7-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-116</ArticleId><ArticleId IdType="pmc">PMC2892457</ArticleId><ArticleId IdType="pubmed">20525351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui YL, et al. Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29. Springerplus. 2013;2:267. doi: 10.1186/2193-1801-2-267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2193-1801-2-267</ArticleId><ArticleId IdType="pmc">PMC3696168</ArticleId><ArticleId IdType="pubmed">23875129</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvadores N, Sanhueza M, Manque P, Court FA. Axonal degeneration during aging and its functional role in neurodegenerative disorders. Front Neurosci. 2017;11:451–451. doi: 10.3389/fnins.2017.00451.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00451</ArticleId><ArticleId IdType="pmc">PMC5591337</ArticleId><ArticleId IdType="pubmed">28928628</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SC, Lin JY, Lo LY, Li ML, Shih SR. Diverse apoptotic pathways in enterovirus 71-infected cells. J. Neurovirol. 2004;10:338–349. doi: 10.1080/13550280490521032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490521032</ArticleId><ArticleId IdType="pubmed">15765805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Lai YK, Yu CK, Juang JL. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol. 2007;9:2676–2688. doi: 10.1111/j.1462-5822.2007.00988.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.00988.x</ArticleId><ArticleId IdType="pubmed">17581253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung WH, Lee IT, Hsieh HL, Yang CM. EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes. J. Cell Physiol. 2010;224:376–386. doi: 10.1002/jcp.22133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22133</ArticleId><ArticleId IdType="pubmed">20333648</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263–3269. doi: 10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, Kung HF, He ML. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 2011;16:51–58. doi: 10.3851/IMP1720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1720</ArticleId><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 2004;24:439–454. doi: 10.1089/1079990041689665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/1079990041689665</ArticleId><ArticleId IdType="pubmed">15320958</ArticleId></ArticleIdList></Reference><Reference><Citation>Solaroglu I, Cahill J, Jadhav V, Zhang JH. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke. 2006;37:1123–1128. doi: 10.1161/01.STR.0000208205.26253.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000208205.26253.96</ArticleId><ArticleId IdType="pubmed">16514095</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-H, Oyarzabal EA, Hong J-S. Preparation of rodent primary cultures for neuron-glia, mixed glia, enriched microglia, and reconstituted cultures with microglia. Methods Mol. Biol. 2013;1041:231–240. doi: 10.1007/978-1-62703-520-0_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-520-0_21</ArticleId><ArticleId IdType="pmc">PMC4788376</ArticleId><ArticleId IdType="pubmed">23813383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Ennis J, Turner JD, Chu JJ. Single dose of an adenovirus vectored mouse interferon-alpha protects mice from lethal EV71 challenge. Antivir. Res. 2016;134:207–215. doi: 10.1016/j.antiviral.2016.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.09.003</ArticleId><ArticleId IdType="pmc">PMC7113890</ArticleId><ArticleId IdType="pubmed">27623347</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael BD, et al. Astrocyte- and neuron-derived CXCL1 drives neutrophil transmigration and blood-brain barrier permeability in viral encephalitis. Cell Rep. 2020;32:108150. doi: 10.1016/j.celrep.2020.108150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108150</ArticleId><ArticleId IdType="pmc">PMC7548103</ArticleId><ArticleId IdType="pubmed">32937134</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawant KV, et al. Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions. Sci. Rep. 2016;6:33123–33123. doi: 10.1038/srep33123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33123</ArticleId><ArticleId IdType="pmc">PMC5021969</ArticleId><ArticleId IdType="pubmed">27625115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosking MP, Liu L, Ransohoff RM, Lane TE. A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog. 2009;5:e1000648. doi: 10.1371/journal.ppat.1000648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000648</ArticleId><ArticleId IdType="pmc">PMC2766051</ArticleId><ArticleId IdType="pubmed">19893623</ArticleId></ArticleIdList></Reference><Reference><Citation>McCandless EE, Zhang B, Diamond MS, Klein RS. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl Acad. Sci. USA. 2008;105:11270–11275. doi: 10.1073/pnas.0800898105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0800898105</ArticleId><ArticleId IdType="pmc">PMC2495012</ArticleId><ArticleId IdType="pubmed">18678898</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest Ophthalmol. Vis. Sci. 1998;39:1854–1862.</Citation><ArticleIdList><ArticleId IdType="pubmed">9727408</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin G, et al. Durable and controlled depletion of neutrophils in mice. Nat. Commun. 2020;11:2762. doi: 10.1038/s41467-020-16596-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16596-9</ArticleId><ArticleId IdType="pmc">PMC7265525</ArticleId><ArticleId IdType="pubmed">32488020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruhn KW, Dekitani K, Nielsen TB, Pantapalangkoor P, Spellberg B. Ly6G-mediated depletion of neutrophils is dependent on macrophages. Results Immunol. 2016;6:5–7. doi: 10.1016/j.rinim.2015.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rinim.2015.12.001</ArticleId><ArticleId IdType="pmc">PMC4711394</ArticleId><ArticleId IdType="pubmed">26870635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh D, Basu A. Japanese encephalitis-a pathological and clinical perspective. PLoS Negl. Trop. Dis. 2009;3:e437–e437. doi: 10.1371/journal.pntd.0000437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000437</ArticleId><ArticleId IdType="pmc">PMC2745699</ArticleId><ArticleId IdType="pubmed">19787040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung B, Wong V. Severe enterovirus 71 infection. Arch. Dis. Child. 2007;92:593. doi: 10.1136/adc.2007.121525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2007.121525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T, Ooi M-H, Ng LFP. Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front. Microbiol. 2017;8:2249–2249. doi: 10.3389/fmicb.2017.02249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkouveris I, Nikitakis N, Karanikou M, Rassidakis G, Sklavounou A. Erk1/2 activation and modulation of STAT3 signaling in oral cancer. Oncol. Rep. 2014;32:2175–2182. doi: 10.3892/or.2014.3440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2014.3440</ArticleId><ArticleId IdType="pubmed">25174327</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7:122–133. doi: 10.1215/S1152851704001061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1215/S1152851704001061</ArticleId><ArticleId IdType="pmc">PMC1871893</ArticleId><ArticleId IdType="pubmed">15831231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Duan H, Gao M, Zhang H, Peng Y. Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication. Viruses. 2015;7:1344–1356. doi: 10.3390/v7031344.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7031344</ArticleId><ArticleId IdType="pmc">PMC4379574</ArticleId><ArticleId IdType="pubmed">25803100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihle JN. Cytokine receptor signalling. Nature. 1995;377:591–594. doi: 10.1038/377591a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/377591a0</ArticleId><ArticleId IdType="pubmed">7566171</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell JE, Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421. doi: 10.1126/science.8197455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8197455</ArticleId><ArticleId IdType="pubmed">8197455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohori M, Takeuchi M, Maruki R, Nakajima H, Miyake H. FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice. Naunyn Schmiedebergs Arch. Pharm. 2007;374:311–316. doi: 10.1007/s00210-006-0117-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-006-0117-7</ArticleId><ArticleId IdType="pubmed">17123065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohori M, et al. Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. Biochem. Biophys. Res. Commun. 2005;336:357–363. doi: 10.1016/j.bbrc.2005.08.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.08.082</ArticleId><ArticleId IdType="pubmed">16139248</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsham GJ, Abrams CC, King AM, Roosien J, Vlak JM. Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells. J. Gen. Virol. 1991;72:747–751. doi: 10.1099/0022-1317-72-3-747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-72-3-747</ArticleId><ArticleId IdType="pubmed">1848606</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc D, Drugeon G, Haenni AL, Girard M, van der Werf S. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J. 1989;8:2661–2668. doi: 10.1002/j.1460-2075.1989.tb08406.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1989.tb08406.x</ArticleId><ArticleId IdType="pmc">PMC401272</ArticleId><ArticleId IdType="pubmed">2555183</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan YW, Hong WJ, Chu JJ. Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease. Antivir. Res. 2016;133:191–195. doi: 10.1016/j.antiviral.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.08.009</ArticleId><ArticleId IdType="pubmed">27520386</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaseelan, S. et al. Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection. Sci. Transl. Med.11, 10.1126/scitranslmed.aar5759 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31666401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Tee HK, Lee MHP, Sam IC, Chan YF. Enterovirus A71 DNA-launched infectious clone as a robust reverse genetic tool. PloS ONE. 2016;11:e0162771–e0162771. doi: 10.1371/journal.pone.0162771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162771</ArticleId><ArticleId IdType="pmc">PMC5019408</ArticleId><ArticleId IdType="pubmed">27617744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullberg M, et al. Pharmacokinetics of the oral selective CXCR2 antagonist AZD5069: a summary of eight phase I studies in healthy volunteers. Drugs R. D. 2018;18:149–159. doi: 10.1007/s40268-018-0236-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40268-018-0236-x</ArticleId><ArticleId IdType="pmc">PMC5995788</ArticleId><ArticleId IdType="pubmed">29856004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Ma XL, Wei YQ, Wei XW. Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases. Biochim. Biophys. Acta Rev. Cancer. 2019;1871:289–312. doi: 10.1016/j.bbcan.2019.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2019.01.005</ArticleId><ArticleId IdType="pubmed">30703432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 2008;198:1002–1006. doi: 10.1086/591462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591462</ArticleId><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, et al. Serum cytokine profiles of children with human enterovirus 71-associated hand, foot, and mouth disease. J. Med. Virol. 2014;86:1377–1385. doi: 10.1002/jmv.23929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23929</ArticleId><ArticleId IdType="pubmed">24619468</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroleva GA, Karmysheva VY, Lukashev AN. Enterovirus 71 pathogenicity in monkeys and cotton rats. Arch. Virol. 2014;159:1133–1138. doi: 10.1007/s00705-013-1895-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1895-0</ArticleId><ArticleId IdType="pubmed">24158347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, et al. Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes. Virol. J. 2013;10:157–157. doi: 10.1186/1743-422X-10-157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-157</ArticleId><ArticleId IdType="pmc">PMC3680086</ArticleId><ArticleId IdType="pubmed">23693026</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Neuropathology in 2 cases of fatal enterovirus type 71 infection from a recent epidemic in the People’s Republic of China: a histopathologic, immunohistochemical, and reverse transcription polymerase chain reaction study. Hum. Pathol. 2009;40:1288–1295. doi: 10.1016/j.humpath.2009.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2009.01.015</ArticleId><ArticleId IdType="pubmed">19386354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YC, et al. Clinicopathologic features and molecular analysis of enterovirus 71 infection: report of an autopsy case from the epidemic of hand, foot and mouth disease in China. Pathol. Int. 2012;62:565–570. doi: 10.1111/j.1440-1827.2012.02837.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1827.2012.02837.x</ArticleId><ArticleId IdType="pubmed">22827767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 2008;67:162–169. doi: 10.1097/nen.0b013e318163a990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318163a990</ArticleId><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsueh C, et al. Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod. Pathol. 2000;13:1200–1205. doi: 10.1038/modpathol.3880222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/modpathol.3880222</ArticleId><ArticleId IdType="pubmed">11106077</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing J, et al. Pathologic studies of fatal encephalomyelitis in children caused by enterovirus 71. Am. J. Clin. Pathol. 2016;146:95–106. doi: 10.1093/ajcp/aqw089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqw089</ArticleId><ArticleId IdType="pubmed">27357294</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow M, et al. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature. 1987;327:482–486. doi: 10.1038/327482a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/327482a0</ArticleId><ArticleId IdType="pubmed">3035380</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler KL, et al. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 2013;9:e1003240. doi: 10.1371/journal.ppat.1003240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003240</ArticleId><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple BD, Kossmann T, Morganti-Kossmann MC. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow. Metab. 2010;30:459–473. doi: 10.1038/jcbfm.2009.240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2009.240</ArticleId><ArticleId IdType="pmc">PMC2949152</ArticleId><ArticleId IdType="pubmed">19904283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZJ, Cao DL, Zhang X, Ji RR, Gao YJ. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain. 2013;154:2185–2197. doi: 10.1016/j.pain.2013.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2013.07.002</ArticleId><ArticleId IdType="pmc">PMC3899784</ArticleId><ArticleId IdType="pubmed">23831863</ArticleId></ArticleIdList></Reference><Reference><Citation>Habelhah H, et al. ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell Biol. 2001;3:325–330. doi: 10.1038/35060131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35060131</ArticleId><ArticleId IdType="pubmed">11231586</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S, Unsicker K. ERK and cell death: ERK1/2 in neuronal death. FEBS J. 2010;277:22–29. doi: 10.1111/j.1742-4658.2009.07367.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2009.07367.x</ArticleId><ArticleId IdType="pubmed">19843173</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293:386–395. doi: 10.1006/viro.2001.1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Jham BC, Montaner S. The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor: lessons on dysregulated angiogenesis from a viral oncogene. J. Cell Biochem. 2010;110:1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733450</ArticleId><ArticleId IdType="pubmed">20213674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen QL, et al. Activation of p38 MAPK pathway by hepatitis C virus E2 in cells transiently expressing DC-SIGN. Cell Biochem. Biophys. 2010;56:49–58. doi: 10.1007/s12013-009-9069-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-009-9069-0</ArticleId><ArticleId IdType="pubmed">19851890</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Qin X, Zhao L, Wang G, Liu C. Human immunodeficiency virus type 1 Tat induces B7-H1 expression via ERK/MAPK signaling pathway. Cell Immunol. 2011;271:280–285. doi: 10.1016/j.cellimm.2011.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2011.07.005</ArticleId><ArticleId IdType="pubmed">21821233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Zhang H, Zhu M, Luo Z, Peng Y. MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71) Antivir. Res. 2012;93:110–117. doi: 10.1016/j.antiviral.2011.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.11.001</ArticleId><ArticleId IdType="pubmed">22101247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirsten AM, et al. The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD. Pulm. Pharm. Ther. 2015;31:36–41. doi: 10.1016/j.pupt.2015.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2015.02.001</ArticleId><ArticleId IdType="pubmed">25681277</ArticleId></ArticleIdList></Reference><Reference><Citation>De Soyza A, et al. A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis. Eur. Respir. J. 2015;46:1021–1032. doi: 10.1183/13993003.00148-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00148-2015</ArticleId><ArticleId IdType="pubmed">26341987</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Byrne PM, et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir. Med. 2016;4:797–806. doi: 10.1016/S2213-2600(16)30227-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)30227-2</ArticleId><ArticleId IdType="pubmed">27574788</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth-Walter F, et al. Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: an EAACI Taskforce on Immunopharmacology position paper. Allergy. 2019;74:432–448. doi: 10.1111/all.13642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13642</ArticleId><ArticleId IdType="pubmed">30353939</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagensky, O. et al. Increased expression of heme-binding protein 1 early in Alzheimer’s disease is linked to neurotoxicity. Elife8, 10.7554/eLife.47498 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6739868</ArticleId><ArticleId IdType="pubmed">31453805</ArticleId></ArticleIdList></Reference><Reference><Citation>Manglani M, Gossa S, McGavern DB. Leukocyte isolation from brain, spinal cord, and meninges for flow cytometric analysis. Curr. Protoc. Immunol. 2018;121:e44–e44. doi: 10.1002/cpim.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpim.44</ArticleId><ArticleId IdType="pmc">PMC6060638</ArticleId><ArticleId IdType="pubmed">30040211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumaraswami, K. et al. A simple and effective flow cytometry-based method for identification and quantification of tissue infiltrated leukocyte subpopulations in a mouse model of peripheral arterial disease. Int. J. Mol. Sci. 21, 10.3390/ijms21103593 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279164</ArticleId><ArticleId IdType="pubmed">32438752</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>